Angene Chemical
Draw
|
Currency :
Home Products

AG003U4X

106266-06-2 | Risperidone

Chemical structure of Risperidone, CAS 106266-06-2
AG003U4X
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 106266-06-2
Catalog Number AG003U4X(AGN-PC-0OVST8)
Chemical Name Risperidone
IUPAC Name 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
InChI InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3
InChI Key RAPZEAPATHNIPO-UHFFFAOYSA-N
MDL Number MFCD00274576
Molecular Formula C23H27FN4O2
Molecular Weight 410.4845
NSC Number 759895
SMILES O=C1C(CCN2CCC(CC2)C3=NOC4=C3C=CC(F)=C4)=C(N=C5N1CCCC5)C
UNII L6UH7ZF8HC
Synonyms
Consta, Risperdal, R 64,766, R 64766, R-64,766, R-64766, R64,766, R64766, Risperdal Consta, Risperidal, Risperidone, risperidone, 106266-06-2, Risperidal, Risperdal, Rispolept, Risperdal Consta, Risperin, Rispolin, Sequinan, Risperidona, Risperidonum, Risperidal M-Tab, Risperidonum [Latin], Risperidona [Spanish], Risperdal M-Tab, Apexidone, Belivon, Spiron, R 64 766, R 64,766, UNII-L6UH7ZF8HC, R 64766, R-64766, C23H27FN4O2, RAPZEAPATHNIPO-UHFFFAOYSA-N, CHEMBL85, MFCD00274576, L6UH7ZF8HC, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, BRN 4891881, CHEBI:8871, R-64-766, Risperidone, 99%, 3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one, 3-{2-[4-(6-FLUORO-BENZO[D]ISOXAZOL-3-YL)-PIPERIDIN-1-YL]-ETHYL}-2-METHYL-6,7,8,9-TETRAHYDRO-PYRIDO[1,2-A]PYRIMIDIN-4-ONE, NCGC00015883-05, CAS-106266-06-2, DSSTox_CID_25193, DSSTox_RID_80740, DSSTox_GSID_45193, 3-[2-[4-(6-fluoranyl-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one, 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one, risperdone, Psychodal, Zophrenal, Risperdal (TN), 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one, 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one, 3-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino]ethyl}-6,7,8,9-tetrahydro-2-methylpyrido[1,2-a]pyrimidin-4-one, 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one, 4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-, 4H-Pyrido(1,2-a)pyrimidin-4-one, 6,7,8,9-tetrahydro-3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-2-methyl-, 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-, SMR000466323, Risperidone (RIS), Risperidone, placebo, Risperidone [USAN:BAN:INN], SR-01000075399, Relday, Rispen, Risperidone-ISM, HSDB 7580, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one, 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl}-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, Risperidone [USAN:USP:INN:BAN], KS-1106, Risperidone(Risperdal), Risperidone (Risperdal), Lopac-R-118, AC1L1JJU, Prestwick0_001029, Prestwick1_001029, R-118, GTPL96, Risperidone(R 64 766), SCHEMBL27911, MLS000759429, MLS001165758, MLS001424081, US8802672, Risperidone, BIDD:GT0262, R 62 766, SPBio_003078, PYR332, Jsp000573, DTXSID8045193, Risperidone (JP17/USAN/INN), HMS1571M19, HMS2051H07, HMS2089C22, HMS2098M19, HMS2233O11, HMS3373M18, HMS3393H07, HMS3657G13, HMS3715M19, Pharmakon1600-01506038, ZINC538312, ACT04270, BCP08161, Risperidone 1.0 mg/ml in Methanol, Tox21_110253, ANW-42874, BDBM50001885, BG0309, CR0023, NP-202, NSC759895, s1615, STK646402, AKOS005577302, Tox21_110253_1, AC-1306, API0004081, CCG-100930, CS-1619, DB00734, MCULE-4027175053, NC00180, NSC-759895, PB26023, Risperidone, >=98% (HPLC), powder, RTR-001241, NCGC00015883-01, NCGC00015883-02, NCGC00015883-03, NCGC00015883-04, NCGC00015883-06, NCGC00015883-07, NCGC00015883-08, NCGC00015883-11, NCGC00094352-01, NCGC00094352-02, NCGC00094352-03, NCGC00179257-01, 3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one, 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one, 4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6 ,7,8,9-tetrahydro-2-methyl-, AK172045, AN-15065, BC206675, CC-34268, CPD000466323, HY-11018, SAM001246595, SC-16313, AB0004623, LS-134196, TL8000230, TR-001241, AB00514010, EU-0101074, FT-0631037, R0087, SW197348-4, KS-00000760, 4767-EP2269990A1, 4767-EP2272537A2, 4767-EP2272841A1, 4767-EP2275420A1, 4767-EP2275423A1, 4767-EP2280008A2, 4767-EP2280010A2, 4767-EP2298731A1, 4767-EP2298776A1, 4767-EP2301936A1, 4767-EP2308867A2, 4767-EP2308870A2, 4767-EP2308875A1, 4767-EP2316836A1, 66R062, D00426, J10290, Q-4040, AB00514010-09, AB00514010-11, AB00514010-12, AB00514010_13, AB00514010_14, A801409, C-21900, L000510, I01-1156, J-001555, SR-01000075399-2, SR-01000075399-8, BRD-K53857191-001-04-5, BRD-K53857191-001-10-2, Z1522566617, Risperidone, British Pharmacopoeia (BP) Reference Standard, Risperidone, European Pharmacopoeia (EP) Reference Standard, Risperidone, United States Pharmacopeia (USP) Reference Standard, Risperidone, Pharmaceutical Secondary Standard; Certified Reference Material, Risperidone for system suitability, European Pharmacopoeia (EP) Reference Standard, Risperidone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, (risperidone)3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one, 1026102-43-1, 2-(2-(4-(benzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-7,8,9,9a-tetrahydro-1H-pyrido[1,2-a]pyrimidin-4(6H)-one, 2-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-6,7,8,8a-tetrahydro-5H-naphthalen-1-one, 3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one, 3-?[2-?[4-?(6-?fluoro-?1,?2-?benzisoxazol-?3-?yl)?-?1-?piperidinyl]?ethyl]?-?2,?3,?6,?7,?8,?9-?hexahydro-?2-?methyl-4H-?Pyrido[1,?2-?a]?pyrimidin-?4-?one, 3-[2-[4(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl4H-pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6 fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro- 1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl4H-pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidiny]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-A]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[2,1-b]pyrimidin-4-one, 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl}-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimid-in-4-one, 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (Resperidone), 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (risperidone), 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one(risperidone), 3-{2-[4-(6-fluorobenzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one, 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benz-isoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-, 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-methyl-1,3-dihydro-indol-2-one(Norastemizole), buspirone, ripedon, Consta, Risperdal, RISPADAL, D01AZG, Risperidone (JAN/USAN/INN), Risperidone [USAN:INN:BAN], CID5073, C23-H27-F-N4-O2, CP-018, R 64 766, Risperdal, Risperidone, CS-O-02221, R64766, A8514, R64,766, A10797, R-64,766, D018967, 1-(2-Allyl-phenoxy)-3-isopropylamino-propan-2-ol, 3-Ethyl-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one(Risperidone Impurity), 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-one, 4H-Pirido [1,2-a] pirimidina-4-ona, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-il)-1-] piperidinil etil]-6,7,8,9-tetrahidro-2-metil-, 8NU, Risperidone, 99.5%, Dopamine, serotonin, adrenergic and histamine receptors antagonist - 250mg 250mg,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited